CLINICAL AND PLASMA-LEVEL CHARACTERISTICS OF INTRAMUSCULAR AND ORAL LOXAPINE

被引:32
作者
SIMPSON, GM
COOPER, TB
LEE, JH
YOUNG, MA
机构
关键词
D O I
10.1007/BF00431855
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:225 / 232
页数:8
相关论文
共 12 条
[1]  
BISHOP MP, 1970, CURR THER RES CLIN E, V12, P594
[2]  
CLARK ML, 1972, DIS NERV SYST, V33, P791
[3]  
GREENBLATT DJ, 1976, PHARMACOKINETICS PSY
[4]  
HONIGFELD G, 1965, J CLIN PSYCHOL, V21, P65, DOI 10.1002/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO
[5]  
2-I
[6]  
Kirk R.E., 2012, EXPT DESIGN PROCEDUR, V4th, P302
[7]  
OVERALL JE, 1962, PSYCHOL REP, V10, P799
[8]  
Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11
[9]   SOME METHODOLOGICAL CONSIDERATIONS IN EVALUATION OF DRUG-INDUCED EXTRAPYRAMIDAL DISORDERS - STUDY OF EX10-029, A NEW MORPHANTHRIDINE DERIVATIVE [J].
SIMPSON, GM ;
BECKLES, D ;
LEE, JH ;
ISALSKI, Z .
JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1972, 12 (04) :142-+
[10]   DOUBLE-BLIND COMPARISON OF LOXAPINE SUCCINATE AND TRIFLUOPERAZINE IN NEWLY ADMITTED SCHIZOPHRENIC-PATIENTS [J].
SIMPSON, GM ;
CUCULIC, Z .
JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (01) :60-65